Sep 3 |
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
|
Sep 2 |
Gilead Sciences Might Finally Be On Its Way To Higher Stock Prices
|
Sep 2 |
Gilead Sciences, Inc. (NASDAQ:GILD) is favoured by institutional owners who hold 86% of the company
|
Aug 30 |
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.
|
Aug 30 |
Gilead Sciences: Buy This Bargain Before It's Gone
|
Aug 30 |
How Gilead Sciences, Virtus Investment And Hess Midstream Could Put Cash In Your Pocket
|
Aug 30 |
Insider Sale: Johanna Mercier Sells 9,513 Shares of Gilead Sciences Inc (GILD)
|
Aug 28 |
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday
|
Aug 27 |
Gilead Sciences trades in the green for seventh straight session
|
Aug 27 |
“The Adventure Jar,” Showcases a Family Navigating the Challenges of a Cancer Diagnosis and Finding Magic in Time Together
|